Chronic Grape Extract in Crosstraining Athletes: A Randomized Crossover Trial
ConditionPerformance
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-35
SponsorUniversidad de Granada
About this trial
The aim of this study is to investigate the effect of cronic GSE intake in crosstraining may have a favorable impact on biochemical markers, recovery, and performance.
Eligibility criteria
Qualifiers
Age: 18-35 years.
Body mass index: 18.5-30 kg/m2.
Ability to understand the instructions, objectives, and study protocol.
Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
Disqualifiers
History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
Any chronic pathology in which the intake of nutritional supplements, especially use of antioxidant supplements during the 4 weeks prior to the start of the study.
Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
Use of medications that may affect the study results.
Trial design
Treatments tested in this trial
- Grape Seed Extract
- Placebo
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Universidad de Granada
Lead sponsor
Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.
Collaborator
Source ClinicalTrials.gov